Kensey Nash Predicts Orthopedic Growth In 2006 After Orthovita Disappoints
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash expects that updating the Vitoss Foam bone-void filler line will revive sluggish sales to biomaterials company Orthovita in 2006
You may also be interested in...
Kensey Nash’s Orthopedics Business Fortified By New Customers
Kensey Nash inked major supply agreements in the second quarter, expanding the firm's customer base and accelerating the rebound of its biomaterials business
Kensey Nash’s Orthopedics Business Fortified By New Customers
Kensey Nash inked major supply agreements in the second quarter, expanding the firm's customer base and accelerating the rebound of its biomaterials business
Orthopedics In Brief
New CEO for Wright: Gary Henley will take the helm from interim CEO Barry Bays at Wright Medical, effective April 4. Henley brings 24 years of experience in the orthopedic industry. He has been with Orthofix since 1997, spending the past four years as president of the Americas division, and also draws on nearly ten years of experience with Smith & Nephew. Bays has held the interim CEO position since Laurence Fairey resigned the post in October following disappointing third-quarter results (1"The Gray Sheet" Dec. 12, 2005, p. 13). Bays will resume his role as executive chairman, the firm says...